Serous fluids and hematolymphoid disorders

Area of Science:

• Cytopathology
• Hematopathology
• Oncology

Background:

• Diagnosing hematolymphoid neoplasms via fine-needle aspiration (FNA) cytology is complex.
• Evaluating these neoplasms in body fluid presents additional diagnostic challenges.

Purpose of the Study:

• To review the diagnostic challenges in differentiating hematolymphoid neoplasms from reactive lymphocytes in body fluid cytology.
• To highlight the utility of ancillary studies for accurate diagnosis and subclassification.

Main Methods:

• Morphological evaluation of fine-needle aspiration (FNA) cytology samples from body fluids.
• Review of specific morphological features aiding differentiation between reactive and neoplastic lymphocytes.
• Discussion of ancillary techniques including flow cytometry, immunocytochemistry, cytogenetics, and molecular studies.

Main Results:

• Differentiating low-grade lymphoma from reactive lymphocytes in body fluid is difficult based on morphology alone.
• Reactive lymphocytes may exhibit activation morphology, mimicking neoplastic cells.
• Large cell lymphoma and leukemia cells show distinct morphological features (e.g., large nuclei, immature chromatin, visible nucleoli).

Conclusions:

• Accurate diagnosis and subclassification of hematolymphoid neoplasms in body fluid cytology require a combination of morphological assessment and ancillary studies.
• Flow cytometry is essential for confirming monoclonality.
• Immunocytochemistry, cytogenetics, and molecular studies further aid in precise subclassification.